Ayurveda management of Cerebral Palsy

Phase 2

Completed

• Conditions: Health Condition 1: G80- Cerebral palsy

• Registration Number: CTRI/2020/06/025956
• Lead Sponsor: Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-05-17
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. The age group of 2 to 16 years of either gender.

2. Previously Diagnosed Case of Cerebral palsy.

3. Children suffering from any types of CP due to different etiology.

4. If the participant history of epilepsy well controlled by medication.

5. If the patient has a Mild to Moderate intellectual disability.

5. Parents of CP children have given consent for the participation of their kids in the clinical trial during the study.

Exclusion Criteria

1. Progressive neurological disorder.

2. Children suffering from any systemic illness, Children with severe intractable epilepsy as comorbidity, Congenital disorders like Downâ??s syndrome, Fragile -X syndrome or any congenital, infective disorder, myopathies of genetic origin, severe anaemia, metabolic and endocrinal disorders.

3. Acute illness that would interfere with carrying out the interventions.

4. Recent orthopedic surgery/ casting/ splint, Fixed contractures.

5. Children had received botox (last 1yr) or had undergone phenol block injection or intrathecal baclofen medication.

6. children have a severe intellectual disability.

5. Caregiver not willing to sign the informed consent form.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Lower down/Reduction the spasticity (Modified Ashworth Scale) <br/ ><br>2. Improvement in range of motion (ROM) (Extendable goniometers) <br/ ><br>3. Increase in muscle power (MRC Scale) <br/ ><br>4. Gross motor milestone improvementTimepoint: 2-3 weeks

Secondary Outcome Measures

Name	Time	Method
1. Lower down/Reduction the spasticity (Modified Ashworth Scale) <br/ ><br>2. Improvement in range of motion (ROM) (Extendable goniometers) <br/ ><br>3. Increase in muscle power <br/ ><br>4. All Milestones improvement <br/ ><br>5. Improvement in the quality of life (QOL)Timepoint: 6-7 weeks